EADV 2025: Expanding the Therapeutic Role of Botulinum Toxin in Dermatology

Botulinum toxin has long been known for its aesthetic applications and treatment of spasticity, but its therapeutic potential in dermatology is expanding. Beyond hyperhidrosis, emerging uses include rosacea, alopecia areata, androgenetic alopecia, and hidradenitis suppurativa, though current evidence is primarily based on smaller studies and case reports. At EADV 2025, Oliver Philip Kreyden, MD, dermatologist at Praxisklinik Kreyden in Switzerland, reflected on this evolving landscape and the drug’s potential to improve both dermatologic outcomes and quality of life.